Renal Manifestations in Newly Diagnosed, Antiretroviral Naive Adults with HIV Infection and Their Relationship with CD4+ T-Cell Count: A Cross Sectional Study from a Tertiary Care Hospital in Northeast India

Open Access Original Research Paper Renal Manifestations in Newly Diagnosed, Antiretroviral Naive Adults with HIV Infection and Their Relationship with CD4+ T-Cell Count: A Cross Sectional Study from a Tertiary Care Hospital in Northeast India Running title: Renal manifestations in newly diagnosed HIV Authors: Dr. Rajdeep Paul¹, Dr. Diganta Das², Dr. Chiranjita Phukan³, Dr. Bidyut Kumar Das⁴, Dr. Debleena Nath⁵ ¹Senior Resident, Department of Gastroenterology, Gauhati Medical College and Hospital, Guwahati, Assam, India. ²Associate Professor, Department of Medicine, Gauhati Medical College and Hospital, Guwahati, Assam, India. ³Professor, Department of Medicine, Nalbari Medical College and Hospital, Nalbari, Assam, India. ⁴Assistant Professor, Department of Community Medicine, Gauhati Medical College and Hospital, Guwahati, Assam, India. ⁵Senior Resident, Department of Medicine, Nalbari Medical College and Hospital, Nalbari, Assam, India. Corresponding Author: Dr. Diganta Das, Associate Professor, Department of Medicine, Gauhati Medical College and Hospital, Guwahati 781032, Assam, India. DOI: https://doi.org/10.5281/zenodo.24097819 Received: 26 September 2026, Revised: 16 October 2026, Accepted: 01 November 2026, Online First: 12 November 2026 ABSTRACT Background: Kidney involvement in HIV is often silent at diagnosis, and data from Northeast India on antiretroviral therapy (ART)-naive adults are limited. Aims: To describe the clinical profile of newly diagnosed adults with HIV, to estimate the frequency of renal abnormalities, and to examine their relationship with CD4+ T-cell count. Methods: This hospital-based cross-sectional study enrolled 140 consecutive ART-naive adults with newly diagnosed HIV at Gauhati Medical College and Hospital between October 2023 and September 2024. Serum creatinine with eGFR (CKD-EPI 2021), serum sodium and potassium, urine dipstick, 24-hour urine protein, urine albumin-to-creatinine ratio (ACR) and CD4 count were measured. Correlation and group comparisons were performed. Results: Mean age was 34.14 ± 9.05 years; 69.3% were men. Mean CD4 count was 276.98 ± 135.98 cells/µL, and 43 (30.7%) had counts below 200 cells/µL. Hyponatraemia was present in 94 (67.1%), eGFR below 60 mL/min/1.73 m² in 65 (46.4%), proteinuria above 150 mg/day in 35 (25.0%) and ACR of 30 mg/g or more in 108 (77.1%). Renal dysfunction affected 78 (55.7%). CD4 count correlated positively with eGFR (r = 0.676) and serum sodium (r = 0.711) (both p < 0.001) and negatively with 24-hour urine protein (r = -0.230, p = 0.006) and ACR (r = -0.228, p = 0.007). Renal dysfunction affected 83.7% of patients with CD4 below 200 cells/µL against 43.3% of the rest (OR 6.73, 95% CI 2.73-16.63). Conclusion: More than half of newly diagnosed ART-naive adults had renal abnormalities, and their frequency rose as CD4 count fell. Baseline kidney screening should be routine at diagnosis. Keywords: HIV; Antiretroviral-naive; Kidney diseases; Albuminuria; Proteinuria; Hyponatremia; Glomerular filtration rate; CD4 lymphocyte count INTRODUCTION Kidney disease is one of the more common non-infectious complications of HIV infection. It contributes to hospital admission, limits the choice and dosing of antiretroviral drugs, and is independently associated with death. A systematic review covering 61 studies and more than 200,000 people living with HIV in 60 countries found a pooled prevalence of chronic kidney disease (CKD) of 6.4% with the MDRD equation, 4.8% with CKD-EPI and 12.3% with Cockcroft-Gault, with the highest regional estimates from Africa [1]. These figures describe reduced filtration alone. Once albuminuria, proteinuria and electrolyte disorders are counted, the share of patients with some form of renal abnormality is considerably larger. The spectrum of HIV-related kidney disease has changed over the four decades of the epidemic. In the early years, HIV-associated nephropathy (HIVAN) and HIV immune complex kidney disease dominated renal biopsy series. With wider access to antiretroviral therapy (ART), the incidence of HIVAN has fallen in high-income settings, while acute kidney injury, drug nephrotoxicity, and CKD driven by diabetes, hypertension and ageing have become more prominent [2]. In countries where many patients are still diagnosed late, the older and newer patterns exist side by side, and a single patient may carry several causes of kidney injury at once. Several mechanisms explain why HIV damages the kidney. Glomerular epithelial hyperplasia and podocyte injury are the shared pathological features of HIVAN and HIV immune complex disease, and direct infection of renal epithelial cells has been linked to parenchymal injury, although the route of viral entry into these non-lymphoid cells remains debated [3]. The kidney can act as a reservoir for HIV, and chronic immune activation, genetic predisposition, coinfections and comorbid illness all add to the injury [4]. Host genetics matter as well. In a case-control study of African Americans, two APOL1 risk alleles conferred 29-fold higher odds of HIVAN, and untreated individuals with this genotype were estimated to carry a 50% risk of developing it [5]. These risk alleles are found only on African chromosomes, which partly explains why the HIVAN phenotype is less common in Asian populations and why non-collapsing lesions, interstitial nephritis and immune complex disease make up a larger share of disease elsewhere. Proteinuria is the commonest way in which HIV-related glomerular disease becomes visible. Podocyte dedifferentiation, hyperplasia, cytoskeletal dysregulation and apoptosis disturb the filtration barrier and the slit diaphragm, which allows protein to leak and, in HIVAN, leads to collapse of the glomerular tuft [6]. Proteinuria can also reflect comorbid diabetic or hypertensive kidney disease and tubular injury from drugs. Because of this, guidelines recommend that every patient with HIV have kidney function and urine protein assessed at diagnosis and periodically afterwards. The HIV Medicine Association of the Infectious Diseases Society of America advises estimation of glomerular filtration rate and a test for proteinuria at entry into care, with quantification by albumin-to-creatinine or protein-to-creatinine ratio when screening is positive [7]. Albuminuria is a sensitive early marker of glomerular injury and an established predictor of cardiovascular events. In a randomised trial of previously untreated patients in the United States, 10% had albuminuria before ART, and the albumin-to-creatinine ratio (ACR) correlated positively with HIV RNA (r = 0.25) and negatively with CD4 count (r = -0.25) [8]. In ART-naive outpatients in Uganda, microalbuminuria was found in 18.9%, and a CD4 count below 350 cells/µL was associated with its presence [9]. These observations suggest that kidney injury begins early, is tied to the degree of immunosuppression, and may be partly reversible with treatment. Water and electrolyte disorders are another frequent but less studied part of the renal picture. People with HIV, and particularly those with advanced disease, have altered renal handling of water and solutes, including reduced free water clearance and increased fractional excretion of calcium and magnesium. They are also exposed to fever, diarrhoea, vomiting, opportunistic infections, adrenal insufficiency and drugs that disturb homeostasis [10]. Hyponatraemia is the most common of these disorders. In hospitalised patients in Xinjiang, China, almost 40% were hyponatraemic, and severe hyponatraemia carries higher morbidity and mortality [11]. In a Belgian cohort of 1,196 newly diagnosed, ART-naive patients, 14.8% had hyponatraemia at baseline; these patients had lower CD4 counts (207.5 against 400.4 cells/µL), more AIDS, more hospital admissions and higher mortality [12]. Serum sodium therefore also tracks disease severity. India has one of the largest populations of people living with HIV in the world, and late presentation remains common. Indian data on renal involvement are encouraging in volume but heterogeneous in design. In 510 hospitalised patients in North India, electrolyte disorders were present in 71%, hyponatraemia in 61%, acute renal failure in 15.8%, CKD in 13% and dipstick proteinuria of 1+ or more in 29%; CD4 count correlated positively with creatinine clearance and serum sodium and negatively with proteinuria [13]. In Kolkata, renal involvement was found in 22.9% of ART-naive patients against 13.8% of those on ART, and a CD4 count below 100 cells/µL and low body mass index were associated with renal dysfunction [14]. More recently, a prospective study from Hyderabad of 262 patients on treatment reported a mean eGFR of 57.5 mL/min/1.73 m², proteinuria in 40.1% and acute kidney injury in 27.1%, and biopsy showed chronic and acute tubulointerstitial nephritis, diabetic nephropathy and thrombotic microangiopathy rather than HIVAN [15]. Most of these studies enrolled hospitalised patients or patients already on ART, in whom illness severity, opportunistic infections and drug exposure confound the relationship between HIV and the kidney. Few have measured 24-hour urine protein, ACR and serum electrolytes together in the same group of newly diagnosed, untreated adults. Data from Northeast India are particularly sparse, even though the region has a distinct epidemic, with injection drug use and high rates of hepatitis B and C coinfection in some states. The point at which a person is first diagnosed is also the point at which treatment decisions are made. Knowing the renal status at that moment matters for the choice of regimen, for dose adjustment of drugs such as tenofovir disoproxil fumarate and cotrimoxazole, and for planning follow-up. We therefore studied a consecutive series of newly diagnosed, ART-naive adults at a large tertiary care hospital in Assam. We measured filtration, proteinuria, albumi

Authors

Institutions

Publication Details

Journal
International Journal of Medical Science in Clinical Research and Review
Published
2026-11-12
DOI
https://doi.org/10.5281/zenodo.24097818
Primary Topic
Renal Diseases and Glomerulopathies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Renal Manifestations in Newly Diagnosed, Antiretroviral Naive Adults with HIV Infection and Their Relationship with CD4+ T-Cell Count: A Cross Sectional Study from a Tertiary Care Hospital in Northeast India

Dr. Rajdeep Paul¹, Dr. Diganta Das², Dr. Chiranjita Phukan³, Dr. Bidyut Kumar Das⁴, Dr. Debleena Nath⁵
International Journal of Medical Science in Clinical Research and Review
Renal Diseases and Glomerulopathies
article

Renal Manifestations in Newly Diagnosed, Antiretroviral Naive Adults with HIV Infection and Their Relationship with CD4+ T-Cell Count: A Cross Sectional Study from a Tertiary Care Hospital in Northeast India

Dr. Rajdeep Paul¹, Dr. Diganta Das², Dr. Chiranjita Phukan³, Dr. Bidyut Kumar Das⁴, Dr. Debleena Nath⁵
article en

Abstract

Open Access Original Research Paper Renal Manifestations in Newly Diagnosed, Antiretroviral Naive Adults with HIV Infection and Their Relationship with CD4+ T-Cell Count: A Cross Sectional Study from a Tertiary Care Hospital in Northeast India Running title: Renal manifestations in newly diagnosed HIV Authors: Dr. Rajdeep Paul¹, Dr. Diganta Das², Dr. Chiranjita Phukan³, Dr. Bidyut Kumar Das⁴, Dr. Debleena Nath⁵ ¹Senior Resident, Department of Gastroenterology, Gauhati Medical College and Hospital, Guwahati, Assam, India. ²Associate Professor, Department of Medicine, Gauhati Medical College and Hospital, Guwahati, Assam, India. ³Professor, Department of Medicine, Nalbari Medical College and Hospital, Nalbari, Assam, India. ⁴Assistant Professor, Department of Community Medicine, Gauhati Medical College and Hospital, Guwahati, Assam, India. ⁵Senior Resident, Department of Medicine, Nalbari Medical College and Hospital, Nalbari, Assam, India. Corresponding Author: Dr. Diganta Das, Associate Professor, Department of Medicine, Gauhati Medical College and Hospital, Guwahati 781032, Assam, India. DOI: https://doi.org/10.5281/zenodo.24097819 Received: 26 September 2026, Revised: 16 October 2026, Accepted: 01 November 2026, Online First: 12 November 2026 ABSTRACT Background: Kidney involvement in HIV is often silent at diagnosis, and data from Northeast India on antiretroviral therapy (ART)-naive adults are limited. Aims: To describe the clinical profile of newly diagnosed adults with HIV, to estimate the frequency of renal abnormalities, and to examine their relationship with CD4+ T-cell count. Methods: This hospital-based cross-sectional study enrolled 140 consecutive ART-naive adults with newly diagnosed HIV at Gauhati Medical College and Hospital between October 2023 and September 2024. Serum creatinine with eGFR (CKD-EPI 2021), serum sodium and potassium, urine dipstick, 24-hour urine protein, urine albumin-to-creatinine ratio (ACR) and CD4 count were measured. Correlation and group comparisons were performed. Results: Mean age was 34.14 ± 9.05 years; 69.3% were men. Mean CD4 count was 276.98 ± 135.98 cells/µL, and 43 (30.7%) had counts below 200 cells/µL. Hyponatraemia was present in 94 (67.1%), eGFR below 60 mL/min/1.73 m² in 65 (46.4%), proteinuria above 150 mg/day in 35 (25.0%) and ACR of 30 mg/g or more in 108 (77.1%). Renal dysfunction affected 78 (55.7%). CD4 count correlated positively with eGFR (r = 0.676) and serum sodium (r = 0.711) (both p < 0.001) and negatively with 24-hour urine protein (r = -0.230, p = 0.006) and ACR (r = -0.228, p = 0.007). Renal dysfunction affected 83.7% of patients with CD4 below 200 cells/µL against 43.3% of the rest (OR 6.73, 95% CI 2.73-16.63). Conclusion: More than half of newly diagnosed ART-naive adults had renal abnormalities, and their frequency rose as CD4 count fell. Baseline kidney screening should be routine at diagnosis. Keywords: HIV; Antiretroviral-naive; Kidney diseases; Albuminuria; Proteinuria; Hyponatremia; Glomerular filtration rate; CD4 lymphocyte count INTRODUCTION Kidney disease is one of the more common non-infectious complications of HIV infection. It contributes to hospital admission, limits the choice and dosing of antiretroviral drugs, and is independently associated with death. A systematic review covering 61 studies and more than 200,000 people living with HIV in 60 countries found a pooled prevalence of chronic kidney disease (CKD) of 6.4% with the MDRD equation, 4.8% with CKD-EPI and 12.3% with Cockcroft-Gault, with the highest regional estimates from Africa [1]. These figures describe reduced filtration alone. Once albuminuria, proteinuria and electrolyte disorders are counted, the share of patients with some form of renal abnormality is considerably larger. The spectrum of HIV-related kidney disease has changed over the four decades of the epidemic. In the early years, HIV-associated nephropathy (HIVAN) and HIV immune complex kidney disease dominated renal biopsy series. With wider access to antiretroviral therapy (ART), the incidence of HIVAN has fallen in high-income settings, while acute kidney injury, drug nephrotoxicity, and CKD driven by diabetes, hypertension and ageing have become more prominent [2]. In countries where many patients are still diagnosed late, the older and newer patterns exist side by side, and a single patient may carry several causes of kidney injury at once. Several mechanisms explain why HIV damages the kidney. Glomerular epithelial hyperplasia and podocyte injury are the shared pathological features of HIVAN and HIV immune complex disease, and direct infection of renal epithelial cells has been linked to parenchymal injury, although the route of viral entry into these non-lymphoid cells remains debated [3]. The kidney can act as a reservoir for HIV, and chronic immune activation, genetic predisposition, coinfections and comorbid illness all add to the injury [4]. Host genetics matter as well. In a case-control study of African Americans, two APOL1 risk alleles conferred 29-fold higher odds of HIVAN, and untreated individuals with this genotype were estimated to carry a 50% risk of developing it [5]. These risk alleles are found only on African chromosomes, which partly explains why the HIVAN phenotype is less common in Asian populations and why non-collapsing lesions, interstitial nephritis and immune complex disease make up a larger share of disease elsewhere. Proteinuria is the commonest way in which HIV-related glomerular disease becomes visible. Podocyte dedifferentiation, hyperplasia, cytoskeletal dysregulation and apoptosis disturb the filtration barrier and the slit diaphragm, which allows protein to leak and, in HIVAN, leads to collapse of the glomerular tuft [6]. Proteinuria can also reflect comorbid diabetic or hypertensive kidney disease and tubular injury from drugs. Because of this, guidelines recommend that every patient with HIV have kidney function and urine protein assessed at diagnosis and periodically afterwards. The HIV Medicine Association of the Infectious Diseases Society of America advises estimation of glomerular filtration rate and a test for proteinuria at entry into care, with quantification by albumin-to-creatinine or protein-to-creatinine ratio when screening is positive [7]. Albuminuria is a sensitive early marker of glomerular injury and an established predictor of cardiovascular events. In a randomised trial of previously untreated patients in the United States, 10% had albuminuria before ART, and the albumin-to-creatinine ratio (ACR) correlated positively with HIV RNA (r = 0.25) and negatively with CD4 count (r = -0.25) [8]. In ART-naive outpatients in Uganda, microalbuminuria was found in 18.9%, and a CD4 count below 350 cells/µL was associated with its presence [9]. These observations suggest that kidney injury begins early, is tied to the degree of immunosuppression, and may be partly reversible with treatment. Water and electrolyte disorders are another frequent but less studied part of the renal picture. People with HIV, and particularly those with advanced disease, have altered renal handling of water and solutes, including reduced free water clearance and increased fractional excretion of calcium and magnesium. They are also exposed to fever, diarrhoea, vomiting, opportunistic infections, adrenal insufficiency and drugs that disturb homeostasis [10]. Hyponatraemia is the most common of these disorders. In hospitalised patients in Xinjiang, China, almost 40% were hyponatraemic, and severe hyponatraemia carries higher morbidity and mortality [11]. In a Belgian cohort of 1,196 newly diagnosed, ART-naive patients, 14.8% had hyponatraemia at baseline; these patients had lower CD4 counts (207.5 against 400.4 cells/µL), more AIDS, more hospital admissions and higher mortality [12]. Serum sodium therefore also tracks disease severity. India has one of the largest populations of people living with HIV in the world, and late presentation remains common. Indian data on renal involvement are encouraging in volume but heterogeneous in design. In 510 hospitalised patients in North India, electrolyte disorders were present in 71%, hyponatraemia in 61%, acute renal failure in 15.8%, CKD in 13% and dipstick proteinuria of 1+ or more in 29%; CD4 count correlated positively with creatinine clearance and serum sodium and negatively with proteinuria [13]. In Kolkata, renal involvement was found in 22.9% of ART-naive patients against 13.8% of those on ART, and a CD4 count below 100 cells/µL and low body mass index were associated with renal dysfunction [14]. More recently, a prospective study from Hyderabad of 262 patients on treatment reported a mean eGFR of 57.5 mL/min/1.73 m², proteinuria in 40.1% and acute kidney injury in 27.1%, and biopsy showed chronic and acute tubulointerstitial nephritis, diabetic nephropathy and thrombotic microangiopathy rather than HIVAN [15]. Most of these studies enrolled hospitalised patients or patients already on ART, in whom illness severity, opportunistic infections and drug exposure confound the relationship between HIV and the kidney. Few have measured 24-hour urine protein, ACR and serum electrolytes together in the same group of newly diagnosed, untreated adults. Data from Northeast India are particularly sparse, even though the region has a distinct epidemic, with injection drug use and high rates of hepatitis B and C coinfection in some states. The point at which a person is first diagnosed is also the point at which treatment decisions are made. Knowing the renal status at that moment matters for the choice of regimen, for dose adjustment of drugs such as tenofovir disoproxil fumarate and cotrimoxazole, and for planning follow-up. We therefore studied a consecutive series of newly diagnosed, ART-naive adults at a large tertiary care hospital in Assam. We measured filtration, proteinuria, albumi

International Journal of Medical Science in Clinical Research and Review
Gauhati Medical College and Hospital (IN)
Good health and well-being
Renal Diseases and Glomerulopathies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon